Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Antares Pharma (ATRS)

Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Antares Pharma 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 USA

www.antarespharma.com P: 609-359-3020

Description:

Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.

Key Statistics

Overview:

Market Capitalization, $K 955,063
Shares Outstanding, K 170,852
Annual Sales, $ 183,980 K
Annual Net Income, $ 46,290 K
Last Quarter Sales, $ 41,560 K
Last Quarter Net Income, $ -2,320 K
60-Month Beta 1.15
% of Insider Shareholders 6.40%
% of Institutional Shareholders 50.41%
Float, K 159,917
% Float 93.60%
Short Volume Ratio 0.26

Growth:

1-Year Return 37.01%
3-Year Return 100.36%
5-Year Return 117.51%
5-Year Revenue Growth 252.32%
5-Year Earnings Growth 162.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 05/10/22
Latest Earnings Date 05/19/22
Earnings Per Share ttm 0.07
EPS Growth vs. Prev Qtr -150.00%
EPS Growth vs. Prev Year -150.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 01/29/99

ATRS Ratios

Ratio
Price/Earnings ttm 79.86
Price/Earnings forward 69.88
Price/Earnings to Growth N/A
Return-on-Equity % 7.43%
Return-on-Assets % 4.92%
Profit Margin % 25.16%
Debt/Equity 0.10
Price/Sales 5.19
Price/Cash Flow 43.97
Price/Book 5.43
Book Value/Share 1.03
Interest Coverage 18.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar